Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Managing patients with recurrent prostate cancer who refuse ADT.
Journal: Nature reviews. Urology
Published: May 05, 2026
Fluid shear stress as a co-stimulatory cue to enhance T cell priming and restore activation in cancer patient T cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 10, 2025
Patient-centered Priorities in Prostate Cancer Survivorship Care.
Journal: Urology
Published: August 31, 2025
Author Correction: Genetically adjusted PSA levels for prostate cancer screening.
Journal: Nature medicine
Published: February 03, 2025
Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort.
Journal: The Prostate
Published: January 20, 2025
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitors.
Journal: The oncologist
Published: October 23, 2024
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer.
Journal: JCI insight
Published: October 03, 2024
Transcriptome-wide association analysis identifies candidate susceptibility genes for prostate-specific antigen levels in men without prostate cancer.
Journal: HGG advances
Published: January 17, 2024
Activation of Dendritic Cells Isolated from the Blood of Patients with Prostate Cancer by Ex Vivo Fluid Shear Stress Stimulation.
Journal: Current protocols
Published: December 04, 2023
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction.
Journal: medRxiv : the preprint server for health sciences
Published: November 14, 2023
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups.
Journal: Nature genetics
Published: October 18, 2023
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.
Journal: International journal of molecular sciences
Published: October 07, 2023
Last Updated: 09/26/2026